{"product_id":"fda-483s-pierre-fabre-pharmaceuticals-yessar-m-hussain-md-parsippany-nj-7-27-2022-austin-tx-3-7-2022","title":"FDA 483s – Pierre Fabre Pharmaceuticals \u0026 Yessar M. Hussain, MD (Parsippany NJ, 7\/27\/2022; Austin TX, 3\/7\/2022)","description":"\u003cb\u003eRequest Contents:\u003c\/b\u003e 483 reports for Human Drugs inspections:\nPierre Fabre Pharmaceuticals, Inc., 8 Campus Dr Ste 2, Parsippany, NJ 07054-4409, Inspection ending 7\/27\/2022 (FEI 3013144400)\nYessar M. Hussain, MD, Austin Neuromuscular Center, 4705 Spicewood Springs Rd Ste 100, Austin, TX 78759-8402, Inspection ending 3\/7\/2022 (FEI 3017724696)","brand":"FDA","offers":[{"title":"Default Title","offer_id":50791083147428,"sku":"FDAFT259","price":89.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/foiadocs.com\/products\/fda-483s-pierre-fabre-pharmaceuticals-yessar-m-hussain-md-parsippany-nj-7-27-2022-austin-tx-3-7-2022","provider":"FOIA Document Source","version":"1.0","type":"link"}